Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

No link found between Coxsackie viruses and pemphigus.

Chicken feather gene mutation helps understand human hair disorders.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Chitosan-based dressings reduce inflammation and speed up skin wound healing.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.